Overexpressed in esophageal adenocarcinoma compared with normal (49). Expression was lower in prostate and breast cancers compared to normal and declined with increasing tumor grade (71–73). Low ferroportin expression levels in pancreatic cancer tissue were significantly associated with poor prognosis (74). The gene discussed is SLC40A1; the disease is pancreatic neoplasm.